Journal of Neuroinflammation · 2019 · 34 citations · 48 references
Life SciencesImmunologyPharmacologyInflammationInnate ImmunityNeuropharmacologyAntidepressant PharmacologyAntidepressant PharmacotherapyInflammatory ProcessesInflammatory SignalingNeuroinflammationSepsis PathophysiologyAntidepressant EfficacyAntidepressant MedicationsAntidepressant ResponseIndoleamine 2, 3-Dioxygenase PathwayInflammatory Mechanisms In DepressionInflammatory Pathway ModulationInflammatory Signal TransductionSelective Serotonin Reuptake Inhibitor Treatment
BACKGROUND: Indoleamine 2, 3-dioxygenase 1 (IDO) is responsible for the progression of the kynurenine pathway. This pathway has been implicated in the pathophysiology of inflammation-induced depression in which conventional antidepressants are not effective. It has been reported that granulocyte-macrophage stimulating factor (GM-CSF) could interfere with the induction of IDO in septic patients. We hypothesized that GM-CSF could exert antidepressant effects through IDO downregulation in a model for acute inflammation-induced depression. METHODS: To produce the model, lipopolysaccharide (LPS) (0.83 mg/kg) was administered intraperitoneally to mice. It has been well documented that LPS mediates IDO overexpression through TLR4/NF-ĸB signaling. In the treatment group, mice received GM-CSF (30 μg/kg, i.p.) thirty minutes prior to LPS injection. A validated selective serotonin reuptake inhibitor, fluoxetine (30 mg/kg i.p.), was also administered to an experimental group 30 min prior to LPS. Depressive-like behaviors were evaluated based on the duration of immobility in the forced swim test. To confirm that GM-CSF interferes with IDO induction in LPS treated mice, real-time PCR was used to quantify IDO mRNA expression. Furthermore, in order to study whether GM-CSF inhibits the TLR4/NF-ĸB signaling pathway, we measured levels ofpNF-ĸB and TLR4 by western blotting. RESULTS: GM-CSF demonstrated significant antidepressant activity in the presence of LPS on immobility (p < .001) and latency (p = .010) times in the forced swim test. In contrast, fluoxetine did not show any antidepressant activity on either immobility (p = .918) or latency (p = .566) times. Furthermore, GM-CSF inhibited the increase in IDO mRNA (p = .032) and protein (p = .016) expression as a result of LPS administration. A similar trend was observed for TLR4 (p = .042) and pNF-ĸB (p = .026) expression as both proteins showed reduced expression levels in the GM-CSF-pretreated group compared to the untreated (LPS) group. CONCLUSION: Our results propose a promising antidepressant effect for GM-CSF possibly through the downregulation of IDO expression. This remedying effect of GM-CSF could be attributed to decreased amounts of TLR4 and active NF-ĸB in the treated mice.
48
Non-normal data: Is ANOVA still a valid option?
María J. Blanca, Rafael Alarcón, Jaume Arnau et al. · Psicothema · 2017 · 1.5K citations · Full text
The Forced Swim Test as a Model of Depressive-like Behavior
Roni Yankelevitch-Yahav, Motty Franko, Avrham Huly et al. · Journal of Visualized Experiments · 2015 · 686 citations · Full text
Oxidative Stress and Psychological Disorders
Samina Salim · Current Neuropharmacology · 2014 · 555 citations · Full text